Addex Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency Ad Hoc Announcement Pursuant to Art. 53 LR ...…
Addex Therapeutics to Report Third Quarter 2022 Financial Results and Host Conference Call on November 11, 2022 Geneva, Switzerland, November 3, 2022 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug…
Addex erhöht ausgegebenes Aktienkapital zur Schaffung eigener Aktien Biotechnologie - Das Biotechunternehmen Addex Therapeutics will sich weitere finanzielle Flexibilität verschaffen....…
Addex Increases Issued Share Capital to Create Treasury Shares Ad Hoc Announcement Pursuant to Art. 53 LR ...…